Pfizer gets FDA nod for Avastin’s biosimilar Zirabev

This article was originally published here

Pfizer said that Zirabev has been approved to treat five types of cancer, including metastatic colorectal cancer; unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer

The post Pfizer gets FDA nod for Avastin’s biosimilar Zirabev appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply